Web-Based Support Program for Adults With Colorectal Cancer Receiving Chemotherapy and Their Caregivers to Manage Symptoms

What this Trial Is About

Researchers are evaluating a web-based dyadic intervention designed to help manage psychoneurological symptoms such as fatigue, depression, sleep problems, pain, and cognitive difficulties in patients with colorectal cancer who are receiving chemotherapy, along with support for their caregivers. These symptoms can severely affect both patient and caregiver quality of life and health outcomes. The study aims to develop and test this novel intervention to reduce symptom burden and improve well-being in cancer care. The intervention, called CRCweb, is developed through interviews and feedback from patient-caregiver pairs to tailor its content. The study includes a prototype usability test and then a pilot clinical trial where 20 patient-caregiver dyads participate in the web-based program over 8 weeks. Throughout this period, patients and caregivers engage with the intervention and complete interviews and surveys. Participants will be involved in surveys and interviews during the 8-week intervention to assess factors such as adherence, acceptability, and symptom changes. Researchers will measure fatigue, depression, sleep quality, pain, cognitive function, and overall quality of life. Health records will also be reviewed. This approach helps understand how feasible and helpful the CRCweb program may be for patients and caregivers managing colorectal cancer symptoms.

A Web-Based Dyadic Intervention for Colorectal Cancer